AMANDA DIXON: Open Payments
NPI 1518328582 · THE WOODLANDS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,851 in 78 payments from 10 companies in 2025. Trend: 2023 $2,360 · 2024 $2,074 · 2025 $1,851
Food & beverage: $1,782Education: $69
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 21 | $602 |
| ViiV Healthcare Company | 17 | $306 |
| ABBVIE INC. | 14 | $270 |
| Merck Sharp & Dohme LLC | 9 | $189 |
| Astellas Pharma US Inc | 4 | $140 |
| Paratek Pharmaceuticals, Inc. | 6 | $137 |
| Smith+Nephew, Inc. | 1 | $106 |
| Shionogi Inc | 4 | $63 |
| Insmed, Inc. | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
Products named: DOVATO, ZERBAXA, NUZYRA, Biktarvy, AVYCAZ, GRAFIX PL, EMBLAVEO, Cresemba.
Industry payments across TX — which companies pay providers there.
